Simultaneous vaccination with prevenar and multicomponent vaccines for children: Interference or no interference?

Human Vaccines

Volumn 5, Issue 1, 2009, Pages 15-17

  Boot, Hein J ^a   Schipper, C Maarten A ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Hexavalent vaccines; Immune response; Meta analysis; Prevenar

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA TOXOID CRM197; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; CHILD; CHILD CARE; CLINICAL TRIAL; CROSS REACTION; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; MENINGOCOCCOSIS; META ANALYSIS; NEISSERIA MENINGITIDIS; PNEUMOCOCCAL INFECTION; SEROCONVERSION; SYSTEMATIC REVIEW; DRUG INTERACTION; IMMUNOLOGY;

CHILD; CLINICAL TRIALS AS TOPIC; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DRUG INTERACTIONS; HUMANS; MENINGOCOCCAL INFECTIONS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINES, COMBINED;

EID: 63349108478     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.5.1.6520     Document Type: Article

References (24)

1. Dodd D. Benefits of combination vaccines: effective vaccination on a simplified schedule. Am J Manag Care 2003; 9:6-12.
2. Decker MD, Edwards KM, Bogaerts HH. Combination Vaccines. Plotkin SA, Orenstein WA. Vaccines. 4th edition. Philadelphia: W.B. Saunders company 2004; 825-61.
3. Buttery JP, Riddell A, McVernon J, et al. Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial. JAMA 2005; 293:1751-8.
4. Dagan R, Eskola J, Leclerc C, Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 1998; 66:2093-8.
5. Kitchin NR, Southern J, Morris R, et al. Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age. Arch Dis Child 2007; 92:11-6.
6. Burrage M, Robinson A, Borrow R, et al. Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect Immun 2002; 70:4946-54.
7. de Vries-Sluijs TE, Hansen BE, van Doornum GJ, et al. A Prospective Open Study of the Efficacy of High-Dose Recombinant Hepatitis B Rechallenge Vaccination in HIV-Infected Patients. J Infect Dis 2008; 197:292-4.
8. European Medicines Agency. EMEA recommends suspension of Hexavac. Doc.Ref. EMEA/297369/2005.
9. European Medicines Agency. Suspension of Hexavac. http:// www.Emea.Europa.Eu/Humandocs/PDFs/EPAR/Hexavac/Hexavac-H-298-Z-28-En.Pdf 2005.
10. Decker MD, Edwards KM. Combination vaccines: problems and promise. J Pediatr 2000; 137:291-5.
11. Denoel PA, Goldblatt D, de Vleeschauwer I, Jacquet JM, Pichichero ME, Poolman JT. Quality of the Haemophilus influenzae Type b (Hib) Antibody Response Induced by Diphtheria-Tetanus-Acellular Pertussis/Hib Combination Vaccines. Clin Vaccine Immunol 2007; 14:1362-9.
12. Schmitt HJ, Knuf M, Ortiz E, Sanger R, Uwamwezi MC, Kaufhold A. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J Pediatr 2000; 137:304-12.
13. Lopalco PL. Use of 7-valent pneumococcal conjugate vaccine in EU. Euro Surveill 2006; 11:061207.3.
14. Tichmann-Schumann I, Soemantri P, Behre U, et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine. Pediatr Infect Dis J 2005; 24:70-7.
15. Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Vaccine 2006; 24:4727-36.
16. Tozzi AE, Azzari C, Bartolozzi G, Esposito S, Fara GM, Giudice ML. Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines? Hum Vaccin 2007; 3:252-9.
17. WHO. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79:255-63.
18. Scheifele DW, Halperin SA, Smith B, Ochnio J, Meloff K, Duarte-Monteiro D. Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age. Vaccine 2006; 24:2057-64.
19. Olivier C, Liese JG, Stojanov S, et al. Immunogenicity and safety of the 7-valent pneumococcal conjugate vaccine (7VPnC-Prevenar) coadministered with a hexavalent DTaP-IPV-HBV/Hib vaccine (Hexavac). ICAAC 42nd Conference Abstract 2002; 242.
20. European Medicines Agency. European Public Assessment Report Hexavac. http://www.Emea.Europa.Eu/Humandocs/Humans/EPAR/Hexavac/Hexavac.
21. Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. J Pediatr 2007; 151:43-9.
22. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. Third Edition edition. Vol. §2.3. New York: John Wiley & Sons 2003.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
24. Käyhty H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals 1994; 22:397-402.